Chronic dietary fat intake modifies the postprandial response of hemostatic markers to a single fatty test meal

Am J Clin Nutr. 2008 Feb;87(2):317-22. doi: 10.1093/ajcn/87.2.317.

Abstract

Background: Hemostasis is the result of a complex equilibrium between coagulation and fibrinolysis, and the influence of different dietary models on this equilibrium is not entirely known.

Objective: The objective was to compare the effects of the chronic intake of different dietary models on postprandial hemostasis.

Design: In a randomized crossover design, 20 healthy men consumed for 28 d each diets rich in monounsaturated fatty acids (MUFAs), saturated fatty acids (SFAs), and carbohydrates plus n-3 fatty acids (CHO/N3). Fasting and postprandial hemostatic factors (factor VII coagulant activity, plasminogen activator inhibitor-1, tissue-type plasminogen activator, d-dimer, and thromboxane B(2)) were measured; meal tests for the postprandial measures were based on butter, virgin olive oil, and walnuts for the SFA, MUFA, and CHO/N3 diets, respectively.

Results: There were no differences in the fasting variables after the dietary periods. After the 3 fatty meals were consumed, we observed an increase in thromboxane B(2) and d-dimer and a reduction in tissue plasminogen activator, irrespective of the dietary model. The MUFA or CHO/N3 meals lowered postprandial concentrations of factor VII coagulant activity, although the reduction was greater after the MUFA-enriched meal. The concentration of plasminogen activator inhibitor-1 was greater after the SFA meal than after the other 2 meals.

Conclusions: The administration of a fatty meal induces a postprandial procoagulant tendency, irrespective of the type of fat consumed. However, the use of a dietary model rich in SFA creates a more procoagulant environment than does a model that includes MUFA or CHO/N3 as the source of fatty acids.

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antifibrinolytic Agents / blood
  • Biomarkers / blood
  • Blood Coagulation*
  • Cross-Over Studies
  • Dietary Fats / administration & dosage*
  • Factor VII / metabolism*
  • Fatty Acids / administration & dosage
  • Fatty Acids, Monounsaturated / administration & dosage
  • Fatty Acids, Omega-3 / administration & dosage
  • Fatty Acids, Unsaturated / administration & dosage
  • Female
  • Fibrin Fibrinogen Degradation Products / metabolism*
  • Hemostasis
  • Humans
  • Male
  • Plasminogen Activator Inhibitor 1 / blood*
  • Postprandial Period*
  • Reference Values
  • Thromboxane B2 / blood*
  • Tissue Plasminogen Activator / blood*

Substances

  • Antifibrinolytic Agents
  • Biomarkers
  • Dietary Fats
  • Fatty Acids
  • Fatty Acids, Monounsaturated
  • Fatty Acids, Omega-3
  • Fatty Acids, Unsaturated
  • Fibrin Fibrinogen Degradation Products
  • Plasminogen Activator Inhibitor 1
  • SERPINE1 protein, human
  • fibrin fragment D
  • Thromboxane B2
  • Factor VII
  • Tissue Plasminogen Activator